Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

NIH pauses study of moderate drinking amid concerns of alcohol industry involvement

The National Institutes of Health (NIH) has halted enrollment in a $100 million, 10-year study of moderate alcohol intake and its effect on cardiovascular health amid concerns over conflicts of interest with the beverage industry.

  • Read more about NIH pauses study of moderate drinking amid concerns of alcohol industry involvement

Beta-blockers equally effective for blacks, whites with HFrEF

A study published May 8 in the Journal of the American Heart Association suggests black and white patients with heart failure with reduced ejection fraction (HFrEF) derive similar benefit from beta-blockers, despite conflicting previous reports.

  • Read more about Beta-blockers equally effective for blacks, whites with HFrEF

Combination of wearables, AI may help ID onset of cardiovascular disease

Medicare now covers a supervised exercise therapy for peripheral artery disease (PAD), according to CMS, a decision that will likely result in other insurers following this example.

Wearable sensors and artificial intelligence (AI) could help predict the onset of cardiovascular disease by assessing an individual's changes in aerobic responses, according to new research published on Feb. 23 in the Journal of Applied Physiology.

  • Read more about Combination of wearables, AI may help ID onset of cardiovascular disease

AI can ID small vessel disease with 85% accuracy

Researchers at Imperial College London and the University of Edinburgh have developed machine learning software that detects small vessel disease (SVD)—which can ultimately cause stroke.

  • Read more about AI can ID small vessel disease with 85% accuracy

Acetaminophen may protect against acute kidney injury after pediatric heart surgery

childrens-health-doctors_thumb.jpg

Acetaminophen after pediatric heart surgery was associated with an increasingly protective effect against acute kidney injury (AKI), according to an analysis of separate cohorts at two children’s hospitals.

  • Read more about Acetaminophen may protect against acute kidney injury after pediatric heart surgery

Excessive patient deaths spur investigation into Houston heart transplant center

Jeffrey Morgan, MD

Jeffrey Morgan, MD

Baylor St. Luke’s Medical Center in Houston continues to tout itself as one of the top heart transplant centers in the country, even as quality measures lag well behind national averages.

  • Read more about Excessive patient deaths spur investigation into Houston heart transplant center

‘Moving the goalposts’? ISCHEMIA investigators defend endpoint change

Goal

The investigators of the anticipated ISCHEMIA trial have published a paper in Circulation: Cardiovascular Quality and Outcomes defending their late addition of “softer” outcomes to their primary composite endpoint.

  • Read more about ‘Moving the goalposts’? ISCHEMIA investigators defend endpoint change

AHA to provide $10M in venture capital to combat heart disease, stroke

The American Heart Association, along with co-financers Philips and the University of Pittsburgh Medical Center (UPMC), will provide $30 million in venture capital to fund heart disease and stroke innovation.

  • Read more about AHA to provide $10M in venture capital to combat heart disease, stroke

Paroxysmal AFib burden linked to higher stroke risk

Even for patients with intermittent atrial fibrillation (AFib), the amount of time spent in an arrhythmic state is strongly associated with an increased risk of stroke, researchers reported in JAMA Cardiology.

  • Read more about Paroxysmal AFib burden linked to higher stroke risk

His bundle pacing trumps right ventricular approach in single-center study

A His bundle pacing (HBP) strategy was associated with a significant reduction in hospitalizations for heart failure when compared to pacemaker implantation via the right ventricle, according to a study published online May 14 in the Journal of the American College of Cardiology.

  • Read more about His bundle pacing trumps right ventricular approach in single-center study

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …787
    • Page 788
    • Page 789
    • Page 790
    • Current page 791
    • Page 792
    • Page 793
    • Page 794
    • Page 795 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme